Linde plc

Linde plc Earnings Recaps

LIN Materials 3 recaps
Next earnings: February 11, 2027 (estimated) · full calendar
Q3 2026 Oct 30, 2026

Linde’s shares fell 1.0% after earnings, a roughly flat reaction. Sales and EPS reached quarterly records, but underlying growth was concentrated by end market and geography, while operating margin was down year over year and flat excluding cost pass-through.

Key takeaways
  • Sales were $9.4 billion, up 9%; underlying sales growth was 5% after currency, cost pass-through, acquisitions and engineering contributions.
  • Volume rose 2%, roughly split between project backlog and organic growth; prices increased 3%, partly reflecting inflation recovery.
  • Operating profit grew 8% to $2.8 billion, and EPS was $4.59. Operating margin was 29.4%, down 30 basis points year over year and flat excluding cost pass-through.
  • Growth varied across markets: electronics rose 15%, chemicals and energy 12%, manufacturing 7%, food and beverage 3%, and healthcare 2%; healthcare growth was mid-single digit excluding Lincare.
  • Linde recorded a $425 million restructuring charge, primarily for severance and portfolio and asset actions. Management is restructuring Lincare and evaluating strategic alternatives.
Q2 2026 Aug 2, 2026

The stock declined 5.9% as investors reacted negatively to margin compression driven primarily by the underperforming U.S. homecare segment, overshadowing strong sales growth and backlog gains.

Key takeaways
  • Sales grew 9% year-over-year to $9.3 billion, with underlying volume and price increases split evenly.
  • Operating margins declined 30 basis points excluding cost pass-through effects, largely due to headwinds in the U.S. homecare business and higher low-margin equipment sales.
  • The Americas segment was the main margin drag, with U.S. homecare portfolio struggles and the mix impact of hardgoods diluting margins.
  • Backlog increased by $1 billion to a record $8.1 billion, fueled by electronics wins and ongoing project developments.
  • EPS rose 10% to $4.50, supported by higher net income and a lower share count, but margin pressures raise concerns on near-term profitability.
Q1 2026 May 2, 2026

Linde’s first quarter results were met with a neutral market reaction, as shares closed up 1.4% after earnings. The quarter showed steady mid-single digit growth in several key end markets, though management flagged ongoing softness in European operations and continued cautiousness regarding impacts from geopolitical events.

Key takeaways
  • Adjusted EPS rose 10% to $4.33, with operating margin reaching 30% and return on capital remaining at 24%.
  • Total sales grew 8% year over year to $8.8 billion, though were flat sequentially.
  • Healthcare end-market grew 1%, held back by flat U.S. home care volumes due to policy changes; food & beverage and electronics grew 5% and 10%, respectively, with electronics supported by AI chip-related demand.
  • Industrial end market growth was led by the Americas; EMEA volumes remained pressured in chemicals, energy, and metals due to production shifting outside Continental Europe.
  • Helium supply remains well managed despite global shortages, with Linde focused on contracted long-term business rather than spot sales for the remainder of the year.